BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Archemix Corporation 

148 Sidney Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-621-7700 Fax: 617-621-9300


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Geron Corporation (GERN): A Tribute to Alex Barkas 11/23/2011 10:06:47 AM    More...
Baxter International, Inc. (BAX) Announces Acquisition of All Hemophilia-Related Assets of Archemix Corporation and an Exclusive License of Its Anti-TFPI Aptamer Technology for $30 Million Upfront Plus Possible $285 Million More in Milestones 11/19/2010 7:47:11 AM    More...
miRagen Therapeutics and Archemix Corporation to Collaborate on Conjugated Aptamer-microRNA Therapeutics 7/23/2009 9:29:23 AM    More...
Archemix Corporation and Dicerna Pharmaceuticals to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics 7/21/2009 6:53:02 AM    More...
Archemix Corporation Appoints Ken Bate as President and Chief Executive Officer 5/6/2009 7:07:25 AM    More...
Archemix Corporation Initiates Phase 2a for Lead Aptamer Product Candidate ARC1779 3/30/2009 8:47:03 AM    More...
Archemix Corporation Merger with NitroMed, Inc. (NTMD) Falls Through 1/28/2009 8:29:08 AM    More...
Archemix Corporation Announces Continued Progress with Business Strategy 1/27/2009 2:20:04 PM    More...
GlaxoSmithKline (GSK) (JOBS) and Archemix Corporation Form Strategic Alliance Worth $1.4 Billion to Develop Aptamers to Treat Inflammatory Diseases 12/23/2008 6:50:27 AM    More...
Archemix Corporation Announces ARC1779 Data to Be Presented at Upcoming American Society of Hematology Annual Meeting, December 6-9, 2008 12/4/2008 9:17:14 AM    More...
123456